Skip to main content
Clinical Trials/JPRN-UMIN000022815
JPRN-UMIN000022815
Recruiting
未知

A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorder - A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorder

Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,0 sites30 target enrollmentSeptember 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
obsessive-compulsive disorder
Sponsor
Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2016
End Date
June 23, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The exclusion criteria for patients and healthy controls were: (1\) cardiac pacemakers or other metallic implants or artifacts; (2\) other factors.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorder
JPRN-jRCT1051180029akamae takashi30
Completed
Phase 3
Fluvoxamine in Long COVIDong or Post COVID syndrome.Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis.U09.9
IRCT20220526054990N1Artesh University of Medical Sciences96
Not yet recruiting
Phase 4
To assess the effectiveness and safety of adding L-methyltetrahydrofolate in addition to fluvoxamine in patients with Obsessive compulsive DisorderHealth Condition 1: F42- Obsessive-compulsive disorder
CTRI/2024/05/067542PT B.D Sharma UHS Rohtak
Not yet recruiting
Phase 3
Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients.cerebral vascular accidentstroke10007963
NL-OMON30510Medisch Spectrum Twente34
Active, not recruiting
Not Applicable
Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients. - Influence of fluoxetine on brain and muscle activity in chronic stroke patientsThe effect of fluoxetine on brain excitability and muscle activation will be measured in chronic stroke patients (> 6 months after stroke). As secondary measures, also brain activation, phase-synchronization in the brain, and motor function will be studied.MedDRA version: 8.1Level: LLTClassification code 10055221Term: Ischemic stroke
EUCTR2006-005044-86-NLRoessingh Research and Development